7 analysts have shared their evaluations of Lineage (NASDAQ:LINE) during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of ...
Ratings for Lineage Cell Therapeutics (AMEX:LCTX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results